Optimization of a Behavioral Intervention to Increase Physical Activity in Older Adults Living With HIV

NCT05752500 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 196

Last updated 2026-03-17

No results posted yet for this study

Summary

The goal of this clinical trial is to examine 3 interventions designed to increase physical activity in older adults with HIV. We will examine 3 potential components of an intervention package: physical activity coaching, cognitive behavioral therapy targeted toward common barriers to physical activity such as low motivation or chronic pain, and a Fitbit-based social support intervention. Our primary outcome will be physical activity, defined as steps per day. Results will guide choice of intervention components to be used in an optimized behavioral intervention.

Conditions

  • Hiv
  • Physical Inactivity
  • Aging

Interventions

BEHAVIORAL

Cognitive Behavioral Intervention for Physical Activity

Interventionist will use cognitive and behavioral techniques to help the participant increase facilitators and decrease barriers to physical activity, particularly barriers such as lack of motivation, depression, and chronic pain. Meetings will occur every other week for 4 months.

BEHAVIORAL

Social Support for Physical Activity

This component will leverage the social functionality of the Fitbit app, promoting social support and friendly competition via a moderated Facebook group.

BEHAVIORAL

Physical Activity Coaching

The PA coach will meet with the participant to set goals for physical activity (steps) and encourage self-monitoring. Meetings will occur every other week for 4 months.

BEHAVIORAL

Brief Advice and Self-Monitoring

Participants will receive a single session with brief advice about increasing physical activity, and instructions on how to use their study-provided FitBit.

Sponsors & Collaborators

  • Butler Hospital

    lead OTHER

Principal Investigators

  • Lisa Uebelacker, PhD · Butler Hospital

  • Jason Baker, MD · Hennepin Healthcare

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-21
Primary Completion
2027-07-01
Completion
2027-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05752500 on ClinicalTrials.gov